ND MPJE key terms
ND MPJE · Get comfortable with the vocabulary.
- Durational equivalency
- Related: Refill authorization, Prescription validity period
The rule that a prescription remains valid only for the time period set by law or by the prescriber, after which it cannot be filled without new authorization. North Dakota sets specific limits for Schedule III-V and other prescriptions.
- Prescription validity period
- Related: Durational equivalency, Schedule II prescription
The maximum age a prescription may reach before dispensing is prohibited. It differs by drug schedule and by state, so a pharmacist must apply the shorter of the applicable federal or North Dakota limit.
- Refill authorization
- Related: Durational equivalency, Partial fill
The prescriber's documented permission to dispense additional quantities of a prescription after the initial fill. The number of refills and the time window are limited by federal schedule rules and North Dakota law.
- Partial fill
- Related: Schedule II prescription, Central fill
Dispensing less than the full prescribed quantity. Rules differ for Schedule II versus Schedule III-V and for LTCF or terminally ill patients, and remaining quantities must be documented and filled within stated deadlines.
- Schedule II prescription
- Related: Partial fill, Emergency oral prescription
A prescription for a drug with high abuse potential and accepted medical use, subject to the strictest federal controls: no refills, written or qualifying emergency oral orders, and specific quantity and time limits in North Dakota.
- Emergency oral prescription
- Related: Schedule II prescription, DEA Form 222
An orally transmitted Schedule II order permitted when immediate dispensing is needed. The pharmacist may dispense a limited quantity, must reduce the order to writing, and must obtain a written prescription within the federal deadline.
- DEA Form 222
- Related: CSA registration, Perpetual inventory
The federal order form used to transfer Schedule I and II controlled substances between registrants. It must be completed accurately, and any errors require a new form rather than alteration of the existing one.
- CSA registration
- Related: DEA Form 222, Power of attorney (DEA)
The DEA registration that authorizes a practitioner or pharmacy to handle controlled substances. It must be renewed periodically, kept at the registered location, and updated when the address or ownership changes.
- Power of attorney (DEA)
- Related: DEA Form 222, CSA registration
A written authorization letting a named agent sign DEA order forms on behalf of a registrant. The registrant retains responsibility, and the authorization must be kept with the registration records.
- Perpetual inventory
- Related: Biennial inventory, Record retention
A running record of controlled substance receipts, dispensings, and adjustments that is reconciled against physical counts. It helps detect diversion and supports the biennial inventory required by federal and state rules.
- Biennial inventory
- Related: Perpetual inventory, Record retention
A complete count of all controlled substances on hand, taken at least every two years and kept with related records. It records the date, time, whether the count was taken before or after opening, and the responsible person.
- Record retention
- Related: Biennial inventory, Prescription filing
The required period for keeping prescriptions, inventories, order forms, and other pharmacy records available for inspection. Federal and North Dakota periods differ, so the longer applicable period generally controls.
- Prescription filing
- Related: Record retention, Hard copy prescription
The organized storage of prescription records so they can be retrieved by drug, patient, or prescriber. Schedule II prescriptions are filed separately from Schedule III-V, and electronic records must meet federal and state standards.
- Hard copy prescription
- Related: Prescription filing, E-prescribing
A paper prescription that is manually signed by the prescriber and presented to the pharmacy. It may be transmitted electronically only where permitted, and the original must be retained under applicable filing rules.
- E-prescribing
- Related: Hard copy prescription, Prescription validity period
The electronic transmission of a prescription from a prescriber to a pharmacy. Federal rules allow electronic controlled substance prescriptions only through certified systems, and North Dakota imposes its own requirements.
- Central fill
- Related: Partial fill, Continuous quality improvement program
An arrangement in which a licensed pharmacy prepares or fills prescriptions for another pharmacy. Both pharmacies must be registered and licensed, and responsibility for the dispensed prescription must be clearly assigned.
- Continuous quality improvement program
- Related: Medication error reporting, Quality-related event
A pharmacy's systematic process for identifying, documenting, and analyzing dispensing errors and near misses, then implementing changes to prevent recurrence. North Dakota requires a written program with defined reporting and review steps.
- Medication error reporting
- Related: Continuous quality improvement program, Quality-related event
The required documentation of errors and near misses to the pharmacy's quality program and, where applicable, to the Board. Reporting supports root-cause analysis and is distinct from mandatory patient notification.
- Quality-related event
- Related: Continuous quality improvement program, Medication error reporting
Any event that occurs in the dispensing process that could or did reach the patient and cause harm, including near misses. It triggers review under the pharmacy's continuous quality improvement program.
- Patient counseling
- Related: Medication therapy management, Prescription transfer
The pharmacist's discussion with the patient or caregiver about proper use, storage, precautions, and expected effects of a medication. North Dakota requires an offer to counsel and documentation when counseling is declined.
- Medication therapy management
- Related: Collaborative practice agreement, Patient counseling
A pharmacist-provided service that reviews a patient's medications for appropriateness, effectiveness, safety, and adherence, often under a collaborative practice agreement. It may include monitoring, education, and recommendations to the prescriber.
- Collaborative practice agreement
- Related: Medication therapy management, Prescriptive authority
A written agreement between a pharmacist and a prescriber that authorizes the pharmacist to perform specified patient care functions, such as adjusting therapy or ordering tests, within defined limits and documentation requirements.
- Prescriptive authority
- Related: Collaborative practice agreement, Pharmacist-in-charge
The legal power to initiate, modify, or discontinue drug therapy. For pharmacists it exists only as granted by state law and, where required, a collaborative agreement or protocol.
- Pharmacist-in-charge
- Related: Pharmacy license, Prescriptive authority
The pharmacist designated as responsible for a pharmacy's compliance with licensing, security, recordkeeping, and staffing requirements. North Dakota requires notification to the Board when this role changes.
- Pharmacy license
- Related: Pharmacist-in-charge, Nonresident pharmacy registration
The Board-issued authorization for a pharmacy to operate at a specific location under a designated pharmacist-in-charge. It must be renewed, displayed, and updated when ownership or location changes.
- Nonresident pharmacy registration
- Related: Pharmacy license, Prescription transfer
The authorization an out-of-state pharmacy must obtain to ship prescriptions to patients in North Dakota. It requires compliance with North Dakota dispensing, counseling, and recordkeeping rules as a condition of shipping into the state.
- Prescription transfer
- Related: Patient counseling, Nonresident pharmacy registration
The process of moving a prescription from one pharmacy to another. Federal and state rules govern what information must be exchanged, how many transfers are allowed, and how the transaction is documented at both pharmacies.
- DEA number
- Related: CSA registration, Prescription validity period
The identifier assigned to a registrant that appears on controlled substance prescriptions and order forms. Pharmacists verify its format and validity before dispensing, and misuse can indicate a forged prescription.
- Red flags (prescription)
- Related: Corresponding responsibility, Due diligence
Circumstances suggesting a prescription may be invalid or diverted, such as unusual distance between prescriber and patient, cash payment for high-risk drugs, or patterns of early refills. They create a duty to resolve doubts before dispensing.
- Corresponding responsibility
- Related: Red flags (prescription), Due diligence
The pharmacist's independent legal duty to ensure a controlled substance prescription is issued for a legitimate medical purpose in the usual course of professional practice, regardless of the prescriber's registration.
- Due diligence
- Related: Red flags (prescription), Prescription monitoring program
The documented steps a pharmacist takes to verify a questionable prescription, such as contacting the prescriber, checking prescription monitoring data, and confirming patient identity before deciding whether to dispense.
- Prescription monitoring program
- Related: Due diligence, Red flags (prescription)
A state database that tracks controlled substance dispensing. North Dakota requires pharmacists to report dispensing data and permits or requires checking the database before dispensing certain drugs under specified circumstances.
- Combat Methamphetamine Act
- Related: Behind-the-counter sale, Record retention
Federal law that restricts retail sales of products containing ephedrine, pseudoephedrine, and phenylpropanolamine, setting daily and monthly purchase limits, requiring photo identification, and mandating written or electronic sales logs.
- Behind-the-counter sale
- Related: Combat Methamphetamine Act, Record retention
A sale of a nonprescription product kept in an area not accessible to the public, requiring pharmacist or technician involvement. North Dakota and federal rules impose identification and log requirements for listed precursors.
- Drug Enforcement Administration (DEA) form 106
- Related: Perpetual inventory, CSA registration
The federal report used to document the theft or significant loss of controlled substances. The registrant must notify the DEA field office and complete the form promptly, and North Dakota may require separate notice to the Board.
- Return of controlled substances
- Related: DEA Form 222, Perpetual inventory
The process by which a pharmacy disposes of or transfers controlled substances, such as expired stock or patient returns. Federal rules limit who may accept returns and require documentation of destruction or reverse distribution.
- Security requirements (pharmacy)
- Related: Pharmacist-in-charge, Perpetual inventory
The physical and procedural safeguards a pharmacy must maintain for controlled substances, including locked storage, limited access, and alarm or access controls. They apply after hours and during delivery and are inspected by the Board.
- Unprofessional conduct
- Related: Pharmacy license, Pharmacist-in-charge
Behavior by a licensee that violates Board rules or accepted standards, such as practicing while impaired, falsifying records, or dispensing without required authorization. It can result in discipline, suspension, or license revocation.
- Continuing education requirement
- Related: Pharmacy license, Record retention
The credit hours a pharmacist or technician must complete each renewal cycle, including any mandated topic hours such as law or patient safety. Records must be retained and produced on audit by the Board.
- Technician registration
- Related: Pharmacist-in-charge, Pharmacy license
The Board-issued credential allowing a pharmacy technician to perform delegated tasks under pharmacist supervision. It specifies permitted duties, supervision ratios, and renewal requirements in North Dakota.